PLPeixin Li

Peixin Li

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Peixin Li has a total of 19 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Embolic Lesion Patterns After Transradial Cerebral Angiography: A Secondary Analysis of a Randomized Controlled Trial

    by Chenchen Liu, Peixin Li, Tiancen Fan, Gang Deng, Yihui Wang, Donghui Ao, Hao Huang, Yi Zhang, Yi Xie, Ying Yu, et al.

    Background: Silent cerebral embolization frequently occurs after transradial cerebral angiography and is commonly detected on diffusion‐weighted imaging (DWI). However, the distribution patterns, burden, and procedural determinants of embolic lesions remain incompletely understood. Methods: This prespecified secondary analysis of a randomized controlled trial evaluated embolic lesion patterns following transradial cerebral angiography under different heparin strategies. Patients with postoperative DWI were included. Lesion patterns were characterized by multiplicity, laterality, size, and overall burden. Multivariable Poisson regression identified factors associated with DWI‐positive lesions and lesion distribution patterns. Results: Among 456 patients with evaluable postoperative DWI, embolic lesions were detected in 77 (16.9%). Most lesions were small (P P P =0.044), bilateral involvement (adjusted RR, 1.21 [95% CI, 1.04–1.42]; P =0.015), and high lesion load (adjusted RR, 2.86 [95% CI, 1.02–8.01]; P =0.045). Conclusions: Embolic lesions after transradial cerebral angiography show heterogeneous distribution patterns beyond incidence alone. Characterization of lesion multiplicity, laterality, and burden provides a more nuanced assessment of embolic injury. Continuous pressurized heparinized saline flush is associated with more diffuse lesion patterns, highlighting procedural and technical influences on embolic risk. Registration: URL: chictr.org.cn ; Unique Identifier: ChiCTR2400080902.


  • MicroRNA ‐181 in cardiovascular disease: Emerging biomarkers and therapeutic targets

    by Bingjie Lv, Shaolin He, Peixin Li, Shijiu Jiang, Dazhu Li, Jibin Lin, Mark W. Feinberg

    Cardiovascular disease (CVD) is the leading cause of death worldwide. MicroRNAs (MiRNAs) have attracted considerable attention for their roles in several cardiovascular disease states, including both the physiological and pathological processes. In this review, we will briefly describe microRNA‐181 (miR‐181) transcription and regulation and summarize recent findings on the roles of miR‐181 family members as biomarkers or therapeutic targets in different cardiovascular‐related conditions, including atherosclerosis, myocardial infarction, hypertension, and heart failure. Lessons learned from these studies may provide new theoretical foundations for CVD.